Group One Trading
GMAB icon

Group One Trading’s Genmab GMAB Stock Holding History

Group One Trading’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$665K Sell
24,800
-2,600
-9% -$77.9K ﹤0.01% 3074
2025
Q4 		$844K Buy
27,400
+27,300
+27,300% +$851K ﹤0.01% 3052
2025
Q3 		$3.07K Sell
100
-1,800
-95% -$43.9K ﹤0.01% 7760
2025
Q2 		$39.3K Buy
1,900
+300
+19% +$6.16K ﹤0.01% 5772
2025
Q1 		$31.3K Buy
+1,600
New +$33.6K ﹤0.01% 5515
2023
Q4 		– Sell
-2,000
Closed -$70.5K – 7661
2023
Q3 		$70.5K Buy
+2,000
New +$76.2K ﹤0.01% 4783

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Group One Trading's GMAB Position: Q1 2026 in Review

Group One Trading reduced its Genmab (GMAB) stake by 21% in Q1 2026, selling an estimated $184K and leaving 23,352 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Group One Trading first reported a position in GMAB in Q4 2019 and has held it in 4 quarters since. The position peaked at $909K in Q4 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Group One Trading held 23,352 shares of Genmab worth $627K as of Q1 2026.
  • Group One Trading sold 6,147 Genmab shares in Q1 2026, an estimated $184K.
  • Genmab made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3136 holding.
  • Group One Trading first reported a position in Genmab in Q4 2019 and has held it in 4 quarters since.
  • Group One Trading's Genmab position peaked at $909K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.